Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1981 1
1985 1
1988 1
1993 5
1994 4
1995 4
1996 5
1997 6
1998 4
1999 3
2000 2
2001 6
2002 13
2003 12
2004 5
2005 9
2006 9
2007 5
2008 6
2009 14
2010 7
2011 7
2012 3
2013 6
2014 5
2015 5
2016 4
2017 3
2018 3
2019 3
2020 4
2021 3
2023 4
2024 2
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean nakano s[au] (2,833 results)?
Comprehensive Evaluation of Androgen Receptor Pathway Inhibitors in Metastatic Castration-Sensitive Prostate Cancer: A Multicenter Inverse Probability of Treatment Weighting-Based Study.
Kobayashi K, Tokunaga T, Nagao K, Fujikawa K, Oba K, Takai K, Matsumoto H, Sakano S, Shirataki S, Tei Y, Tabara M, Yoshihiro S, Yano S, Ito H, Kitahara S, Ohmi C, Akao J, Shiraishi K. Kobayashi K, et al. Among authors: sakano s. Clin Genitourin Cancer. 2025 Dec;23(6):102437. doi: 10.1016/j.clgc.2025.102437. Epub 2025 Sep 16. Clin Genitourin Cancer. 2025. PMID: 41076395 Free article.
The Pretreatment Neutrophil-to-Eosinophil Ratio Can Predict Immune-Related Adverse Events and Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors.
Kobayashi K, Sakano S, Matsumoto H, Tsuchida M, Tei Y, Nagao K, Oba K, Kitahara S, Yano S, Shiraishi K. Kobayashi K, et al. Among authors: sakano s. Cureus. 2025 Aug 8;17(8):e89650. doi: 10.7759/cureus.89650. eCollection 2025 Aug. Cureus. 2025. PMID: 40926945 Free PMC article.
Refining the CHAARTED Classification: Clinical Utility of a Novel Integrated Risk Stratification Model Incorporating Gleason Grade and Biochemical Markers in Japanese Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Tokunaga T, Kobayashi K, Nagao K, Fujikawa K, Oba K, Takai K, Matsumoto H, Sakano S, Shirataki S, Tei Y, Tabara M, Yoshihiro S, Yano S, Ito H, Kitahara S, Ohmi C, Akao J, Shiraishi K. Tokunaga T, et al. Among authors: sakano s. Prostate. 2025 Oct;85(14):1323-1331. doi: 10.1002/pros.70019. Epub 2025 Jul 21. Prostate. 2025. PMID: 40685996
Clinical significance of early kinetics of C‑reactive protein in patients with advanced urothelial carcinoma treated with pembrolizumab: Flare response and baseline levels predict oncological outcomes.
Tomisaki I, Harada M, Sakano S, Terado M, Hamasuna R, Harada S, Matsumoto H, Akasaka S, Nagata Y, Minato A, Harada KI, Fujimoto N. Tomisaki I, et al. Among authors: sakano s. Oncol Lett. 2024 Oct 11;28(6):603. doi: 10.3892/ol.2024.14736. eCollection 2024 Dec. Oncol Lett. 2024. PMID: 39525607 Free PMC article.
Prognostic risk score and index including the platelet-to-lymphocyte ratio and lactate dehydrogenase in patients with metastatic or unresectable urothelial carcinoma treated with immune checkpoint inhibitors.
Kobayashi K, Sakano S, Matsumoto H, Yamamoto M, Tsuchida M, Tei Y, Nagao K, Oba K, Kitahara S, Yano S, Yoshihiro S, Yamamoto Y, Ohmi C, Komatsu H, Misumi T, Akao J, Shiraishi K. Kobayashi K, et al. Among authors: sakano s. Jpn J Clin Oncol. 2025 Feb 4;55(2):148-157. doi: 10.1093/jjco/hyae137. Jpn J Clin Oncol. 2025. PMID: 39373462 Free article.
Comparative Efficacy of Avelumab Maintenance Therapy Versus Continued Chemotherapy Followed by Pembrolizumab in Metastatic Urothelial Carcinoma With No Progression After 4 Cycles of Chemotherapy: A Retrospective Study Using Propensity Score Matching.
Kobayashi K, Matsumoto H, Sakano S, Yamamoto M, Tsuchida M, Tei Y, Nagao K, Oba K, Kitahara S, Yano S, Yoshihiro S, Yamamoto Y, Ohmi C, Komatsu H, Misumi T, Akao J, Shiraishi K. Kobayashi K, et al. Among authors: sakano s. Clin Genitourin Cancer. 2024 Dec;22(6):102212. doi: 10.1016/j.clgc.2024.102212. Epub 2024 Aug 23. Clin Genitourin Cancer. 2024. PMID: 39270620
167 results